Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development
Development of a Novel Technique for PET/MRI Tracer Kinetic Analysis for Urologic Pelvic Malignancy
Sponsor: NYU Langone Health
Listed as NCT02106416, this NA trial focuses on Bladder Cancer and Prostate Cancer and remains completed. Sponsored by NYU Langone Health, it has been updated 9 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2019 — Jan 2021 [monthly]
Completed NA
-
Jun 2018 — Jun 2019 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
-
Jun 2017 — Oct 2017 [monthly]
Completed NA
-
Feb 2017 — Jun 2017 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NYU Langone Health
For direct contact, visit the study record on ClinicalTrials.gov .